ConductScience.org, home

Paper6252829

Comparative in vitro activities of cefotaxime and ceftizoxime (FK749): new cephalosporins with exceptional potency.

Greenwood D and 3 others. Antimicrob Agents Chemother, 1980. Cited by 82 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Comparative in vitro activities of cefotaxime and ceftizoxime (FK749): new cephalosporins with exceptional potency. Papers, record 6252829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6252829

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparative in vitro activities of cefotaxime and ceftizoxime (FK749): new cephalosporins with exceptional potency.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1980
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
82
iCite
Relative citation ratio, by iCite
4.5
iCite
Revised in PubMed
2021-05-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Greenwood DD
2Pearson NN
3Eley AA
4O'Grady FF

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BacteriaMajor topic
CephalosporinsMajor topic
Cefotaxime
Ceftizoxime
Chemical Phenomena
Chemistry
Culture Media
Drug Resistance, Microbial
Escherichia coli
Humans
Models, Biological
Species Specificity
Urinary Bladder

Source PubMed

References7

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,579,140Comparison of the responses of Escherichia coli and proteus mirabilis to seven beta-lactam antibodies.J Infect Dis1973https://conductscience.org/library/papers/4579140PubMed
24,588,037A twelve channel bacterial growth monitoring system.Biomed Eng1973https://conductscience.org/library/papers/4588037PubMed
31,041,500Resistance categories of enterobacteria to beta-lactam antibiotics.J Infect Dis1975https://conductscience.org/library/papers/1041500PubMed
4413,795Experimental evaluation of HR756, a new cephalosporin derivative: pre-clinical study.Infection1977https://conductscience.org/library/papers/413795PubMed
5348,666An in vitro model of the urinary bladder.J Antimicrob Chemother1978https://conductscience.org/library/papers/348666PubMed
6308,505Cefotoxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro.J Antimicrob Chemother1978https://conductscience.org/library/papers/308505PubMed
7308,506Activity of HR 756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods.J Antimicrob Chemother1978https://conductscience.org/library/papers/308506PubMed

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 82 citations.

PMIDTitleJournalYearIn PapersSource
35,401,470The Chemical Relationship Among Beta-Lactam Antibiotics and Potential Impacts on Reactivity and Decomposition.Front Microbiol2022https://conductscience.org/library/papers/35401470PubMed
32,687,523Stability of β-lactam antibiotics in bacterial growth media.PLoS One2020https://conductscience.org/library/papers/32687523PubMed
25,888,392Extended spectrum β-lactamase-producing Escherichia coli forms filaments as an initial response to cefotaxime treatment.BMC Microbiol2015https://conductscience.org/library/papers/25888392PubMed
11,286,322A retrospective analysis of pharmacokinetic-pharmacodynamic parameters as indicators of the clinical efficacy of ceftizoxime.Clin Pharmacokinet2001https://conductscience.org/library/papers/11286322PubMed
7,247,361Activity of a new cephalosporin antibiotic, Ro 13-9904 against dense populations of selected enterobacteria.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7247361PubMed
7,114,839Comparative activities of 13 beta-lactam antibiotics.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/7114839PubMed
6,407,392In vitro antimicrobial activity of eight new beta-lactam antibiotics against penicillin-resistant Neisseria gonorrhoeae.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6407392PubMed
6,324,670Treatment of bacterial meningitis with ceftizoxime.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6324670PubMed
6,323,320Ceftizoxime (FK 749) in vitro antibacterial activity.Infection1984https://conductscience.org/library/papers/6323320PubMed
6,322,676Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6322676PubMed
6,314,887Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6314887PubMed
6,295,270Pharmacokinetics, protein binding, and extravascular distribution of ceftizoxime in normal subjects.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6295270PubMed
6,284,649Elimination of bacteria in biliary tract infections during ceftizoxime therapy.Infection1982https://conductscience.org/library/papers/6284649PubMed
6,272,629In vitro activity of ceftizoxime against Bacteroides fragilis: comparison with benzylpenicillin, cephalothin, and cefoxitin.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6272629PubMed
6,100,425Elimination kinetics of ceftizoxime in humans with and without renal insufficiency.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6100425PubMed
3,888,599Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs1985https://conductscience.org/library/papers/3888599PubMed
3,466,569Effect of medium, pH, and inoculum size on activity of ceftizoxime and Sch-34343 against anaerobic bacteria.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3466569PubMed
3,319,505In vitro antibacterial effects of cephalosporins.Drugs1987https://conductscience.org/library/papers/3319505PubMed
2,327,757Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2327757PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6252829

GET https://conductscience.org/api/papers/v1/6252829/authors